Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome-Reference-Cited by-同舟云学术

Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome

Published:2019-05-07 Issue:7 Volume:39 Page:975-980
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Kurek Eken Meryem¹^ORCID,Sahin Ersoy Gülçin²^ORCID,Yayla Abide Cigdem³^ORCID,Sanverdi İlhan³,Devranoglu Belgin³,Kutlu Tayfun³,Çevik Özge⁴

Affiliation:

1. Department of Obstetric and Gyneacology—Aydın, Adnan Menderes University Medical Faculty, Aydın, Turkey;

2. Jinemed Private Hospital—İstanbul, Turkey;

3. Department of Reproductive Endocrinology and Infertility—İstanbul, Zeynep Kamil Maternal and Children Educational and Research Hospital, İstanbul,Turkey;

4. Department of Biochemistry—Aydın, Adnan Menderes University Medical Faculty, Aydın, Turkey

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2019.1581754

Reference33 articles.

1. Polycystic Ovary Syndrome: A Syndrome of Ovarian Hypersensitivity to Insulin?

2. Obesity and polycystic ovary syndrome

3. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis

4. Burtis CA, Ashwood ER. 1994. Tietz textbook of clinical chemistry, 2nd ed. Philadelphia, PA: Saunders. p. 1850–1851

5. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum level of neuregulin 4 and insulin resistance in polycystic ovary syndrome patients in Iraq;AIP Conference Proceedings;2024

2. Study of neuregulin-4 levels in newly diagnosed type 2 diabetes mellitus;Journal of Family Medicine and Primary Care;2023-11

3. Metabolic characteristics of obese patients with polycystic ovarian syndrome: a meta-analysis;Gynecological Endocrinology;2023-07-31

4. Evaluation of Nrg4 and thiol/disulfide homeostasis in patients with GDM;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-06

5. The Reliability of Serum Neuregulin-4 as a Marker of Polycystic Ovarian Syndrome with Respect to Adiposity Parameters;Clinical and Experimental Obstetrics & Gynecology;2023-04-23